Astra Zeneca
- All
- News
- Videos
- Web Stories
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
- Wednesday November 27, 2024
- India News | Indo-Asian News Service
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
- www.ndtv.com
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
- Thursday May 2, 2024
- India News | NDTV Newsdesk
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
- www.ndtv.com
-
Oxford Vaccine Partner Plans Trials In India, Manufacturing Soon
- Tuesday July 21, 2020
- India News | Edited by Anindita Sanyal
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK.
- www.ndtv.com
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
- Wednesday November 27, 2024
- India News | Indo-Asian News Service
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
- www.ndtv.com
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
- Thursday May 2, 2024
- India News | NDTV Newsdesk
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
- www.ndtv.com
-
Oxford Vaccine Partner Plans Trials In India, Manufacturing Soon
- Tuesday July 21, 2020
- India News | Edited by Anindita Sanyal
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK.
- www.ndtv.com